Home/ Stocks/ NTHI

NeOnc Technologies Holdings, Inc. Common Stock

NTHI XNAS

$5.45 -1.04 (-16.02%) ▼ 15-min delayed

Open

$6.50

High

$6.79

Low

$5.35

Volume

245.2K

Market Cap

$137.81M

About NeOnc Technologies Holdings, Inc. Common Stock

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 5 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$40.0K	$-62,146,210	$-3.20
FY 2025	$40.0K	$-62,146,210	$-3.20
Q3 2025	$0	$-8,615,920	$-0.45
Q2 2025	$0	$-5,680,170	$-0.30

Related Market News

No specific coverage for NTHI yet. Check out our latest market news or earnings calendar.

Get NTHI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on NeOnc Technologies Holdings, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.